The goal of this educational intervention is to inform clinicians on new therapeutic options and medical advances for the treatment of lung cancer that can be implemented in an effort to reduce lung cancer related deaths. It will provide physicians and other healthcare professionals with information that will improve their competence and ultimately improve patient outcomes. By providing them with important therapeutic and standard of care developments, this intervention will educate oncologists on best practices for treating the disease. 

Learning Objectives and Target Audience

At the conclusion of this activity, participants will be able to:

·       Describe the appropriate selection of diagnostic modalities in the workup of a patient with suspected lung cancer;

·       Identify how to evaluate patients with malignant airway obstruction, mediastinal/hilar adenopathy, and peripheral lung lesions;

·       State the role of surgical resection for the treatment of locally advanced and oligometastatic lung cancer;

·       Relate how testing approaches inform clinical decision-making for the treatment of advanced NSCLC in multiple lines of care;

·       Discuss novel non-invasive strategies for detection of lung cancer;

·       Report key clinical trial findings on the use of immunotherapeutic strategies in locally advanced and advanced NSCLC;

·       Explain the application of chemotherapeutic and targeted approaches to NSLC;

·       Discuss the side effects associated with new chemotherapeutic agents and their management.

This activity has been designed for physicians and other healthcare professionals interested in the prevention and treatment of lung cancer.

Click here for original website